High expression of CD8 in the tumor microenvironment is associated with PD-1 expression and patient survival in high-grade serous ovarian cancer-Reference-Cited by-同舟云学术

High expression of CD8 in the tumor microenvironment is associated with PD-1 expression and patient survival in high-grade serous ovarian cancer

Published:2022-09-23 Issue:3 Volume:19 Page:246-256
ISSN:1307-699X
Container-title:Journal of Turkish Society of Obstetric and Gynecology
language:
Short-container-title:tjod

Author:

Ölmez Fatma^ORCID,Oğlak Süleyman Cemil^ORCID,Ölmez Ömer Fatih^ORCID,Akbayır Özgür^ORCID,Yılmaz Ercan^ORCID,Akgöl Sedat^ORCID,Konal Merve^ORCID,Seyhan Niyazi Alper^ORCID,Kinter Alp Koray^ORCID

Publisher

Galenos Yayinevi

Subject

Obstetrics and Gynecology

Reference34 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. 2. Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ 2020;371:m3773.

3. Epidemiology of epithelial ovarian cancer;PM;Best Practice & Research Clinical Obstetrics & Gynaecology,2017

4. Serous Epithelial Ovarian Cancer: Retrospective Analysis of 260 Cases;Akgöl;Aegean J Obstet Gynecol,2021

5. 5. Öcal E, Oğlak SC. The Effect of Lymph Node Dissection on Survival in Patients with Advanced Stage (Stage IIIC and IV) Ovarian Cancer. Medical Journal of Mugla Sitki Kocman University 2020;7:40-4.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival;Gynecologic Oncology;2024-05

2. Clinicopathological and Survival Characteristics of Mismatch Repair Status and PD-1 Expression in Serous Ovarian Cancer;Journal of the College of Physicians and Surgeons Pakistan;2023-06-01